title: Assessing the impact of NICE guidance on the prescribing of hormonal treatments of breast cancer in England.
authors.affiliation: Department of, Pharmacy, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, UK.|School of Pharmacy, Keele University, Keele, Staffordshire, UK.
authors.forename: Raymond W
authors.initials: RW
authors.lastname: Fitzpatrick
authors.affiliation: School of Pharmacy, Keele University, Keele, Staffordshire, UK.
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Pate
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004739:England; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D012189:Retrospective Studies
chemical_list: D018931:Antineoplastic Agents, Hormonal